CClinicalTrials.gg
CompletedNCT04879290EXTUBO2Updated Apr 2, 2026

Comparison of Two FiO2 (1 or 0.5) for Tracheal Extubation in Post-anesthesia Care Unit

An interventional study of FiO2 0.5 and FiO2 1 in Anesthesia, Atelectasis and Postoperative Complications, sponsored by University Hospital, Caen. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-04-02.

Sponsored by University Hospital, Caen · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
119
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of the study is to assess the optimal fraction of inspired oxygen (0.5 or 1) for extubation or removal of a supraglottic airway device after general anesthesia.

Read the detailed description

During pre-anesthesia visit, eligible patients receive oral and written information of the study and potential risks.

In the operating room all patients giving a written informed consent will undergo at the end of surgery a screening to determine eligibility for study entry.

Before emergence from general anesthesia, patients who meet the eligibility requirements will be randomized in a open label manner to receive a 0.5 or 1 FiO2.

02

Conditions studied

  • Anesthesia
  • Atelectasis
  • Postoperative Complications
  • Hypoxemia
  • Hyperoxia

Keywords

  • Post-anesthesia care unit
  • Extubation
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients undergoing general anesthesia, with invasive mechanical ventilation including an airway device (supraglottic airway device or tracheal tube) at their arrival in PACU.
  • ASA physical status classification 1, 2, or 3 stabilized.
  • Surgery performed in emergency operating room department including vascular, digestive, urological and minor trauma surgery or surgery performed in head and neck anesthesia pole block including anterior cervical spine, lumbar disc herniation, cranioplasty, nerve stimulator, vertebroplasty, narrow lumbar canal, simple arthrodesis (less than or equal to two stages), otological, ophthalmological and skin surgery.

Exclusion criteria

Exclusion Criteria:

  • Per-operative hemodynamic instability.
  • Patients with a BMI greater than 35.
  • Patients classified as difficult to intubate and / or ventilate.
  • Heavy surgeries (operating time greater than 4 hours).
  • Patient requiring postoperative non invasive mechanical ventilation
  • Patients with diagnosed COPD
  • SPO2 in room air \< 96% before the intervention.
  • Any patient under guardianship.
  • Pre-operative and / or intra-operative morphine intake.
  • Surgical management of the upper airways (ex : tonsillectomy)
  • Pregnant and lactating women.
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
119 participants (actual)

Study arms

  • Active comparator
    Control Group FiO2=1

    FiO2 = 1 (100%) 10mn before emergence of general anesthesia

    Other: FiO2 1

  • Experimental
    Intervention Group FiO2 0.5

    Fi02 = 0.5 (50%) 10mn before emergence of general anesthesia

    Other: FiO2 0.5

Interventions

  • OtherFiO2 0.5

    Ten minutes before emergence from general anesthesia, the amount of oxygen delivered from the mechanical ventilator called fractional inspired oxygen (FiO2) is set to 0.5 (50%)

  • OtherFiO2 1

    Ten minutes before emergence from general anesthesia, the amount of oxygen delivered from the mechanical ventilator called fractional inspired oxygen (FiO2) is set to 1 (100%)

05

What researchers measure

Primary outcomes

  1. Decrease of oxygen saturation

    Proportions of patients that present a decrease of 4 points of peripheral capillary oxygen saturation (SpO2) measured with pulse oximetry after extubation compared to their baseline room air SpO2

    Time frame: Duration of stay in post-anesthesia care unit, approximately one hour

Secondary outcomes

  1. Duration of emergence

    Elapsed Time between cessation of sedation and extubation (minutes)

    Time frame: Up to one hour

  2. Primary Outcome Timing

    Elapsed time between extubation and decrease of oxygen saturation (minutes)

    Time frame: Up to one hour

  3. Number of risk factors

    Number of factors associated with episodes of hypoxemia : bronchospasm, bronchial congestion (profuse secretions with the need to aspirate the patient several times), loss of upper airway muscle tonus (fall of the tongue).

    Time frame: One hour

  4. Majored decrease of oxygen saturation

    Proportions of patients that present a decrease of 6 points of SpO2 after extubation compared to their baseline room air SpO2

    Time frame: One hour

  5. Corrective measures

    Number of corrective measures (method and oxygen supply equipment used) after hypoxemia and proportion of success.

    Time frame: One hour

  6. PACU length of stay

    Length of stay in post-anesthesia care unit

    Time frame: One hour

06

Study locations

1 site
  • University Hospital, Caen
    Caen, 14033, France
07

References and documents

Publications

  • Comparison of Two FiO2 (1 or 0.5) for Tracheal Extubation in Post-anesthesia Care Unit (EXTUBO2) [abstract]. SFAR 2022 - Livre des résumés; 2022.

Individual participant data

Plan to share: No

08

Registry details

Key details

Study ID
NCT04879290
Lead sponsor
University Hospital, Caen
Responsible party
Sponsor
First posted
May 10, 2021
Start date
Apr 9, 2021
Primary completion
Aug 16, 2021
Completion
Aug 16, 2021
Last update
Apr 2, 2026

Study contacts

Dr KAMGA TOTOUOM, MD
principal investigator · Anesthesiologist
Pr HANOUZ, PhD
study director · Anesthesiologist
Dr BOUTROS, MD
principal investigator · Anesthesiologist

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion